Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Buske

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Advanced Healthcare Materials|December 11, 2012
A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activityYuzhou Wu, Susann Ihme, Michaela Feuring-Buske, et al.
Future Oncology (London, England)|June 6, 2018
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemiaConstantine S Tam, Veronique LeBlond, William Novotny, et al.
Blood|January 25, 2003
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1Nicolas Pineault, Christian Buske, Michaela Feuring-Buske, et al.
Plos One|September 6, 2018
Biomarkers for classification and class prediction of stress in a murine model of chronic subordination stressDominik Langgartner, Andrea M Füchsl, Lisa M Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591Sridhar Vempati, Carola Reindl, Ulla Wolf, et al.
Blood|July 20, 2002
Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cellsChristian Buske, Michaela Feuring-Buske, Carolina Abramovich, et al.
Future Oncology (London, England)|April 1, 2020
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphomaAlexander Grunenberg, Lisa M Kaiser, Stephanie Woelfle, et al.
Blood|October 31, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3Karsten Spiekermann, Ralf J Dirschinger, Ruth Schwab, et al.
Cancers|March 6, 2021
Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's MacroglobulinemiaLisa Marie Kaiser, Mirja Harms, Daniel Sauter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2004
Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemiaVijay P S Rawat, Monica Cusan, Aniruddha Deshpande, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Advanced Healthcare Materials|December 11, 2012
A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activityYuzhou Wu, Susann Ihme, Michaela Feuring-Buske, et al.
Future Oncology (London, England)|June 6, 2018
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemiaConstantine S Tam, Veronique LeBlond, William Novotny, et al.
Blood|January 25, 2003
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1Nicolas Pineault, Christian Buske, Michaela Feuring-Buske, et al.
Plos One|September 6, 2018
Biomarkers for classification and class prediction of stress in a murine model of chronic subordination stressDominik Langgartner, Andrea M Füchsl, Lisa M Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591Sridhar Vempati, Carola Reindl, Ulla Wolf, et al.
Blood|July 20, 2002
Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cellsChristian Buske, Michaela Feuring-Buske, Carolina Abramovich, et al.
Future Oncology (London, England)|April 1, 2020
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphomaAlexander Grunenberg, Lisa M Kaiser, Stephanie Woelfle, et al.
Blood|October 31, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3Karsten Spiekermann, Ralf J Dirschinger, Ruth Schwab, et al.
Cancers|March 6, 2021
Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's MacroglobulinemiaLisa Marie Kaiser, Mirja Harms, Daniel Sauter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2004
Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemiaVijay P S Rawat, Monica Cusan, Aniruddha Deshpande, et al.
Pageof 15